T1	Participants 545 567	operable breast cancer
T2	Participants 590 737	Women with invasive breast cancer were eligible if there were one to three positive lymph nodes or if the node-negative tumor was greater than 1 cm
T3	Participants 1074 1107	2,882 eligible patients enrolled.
T4	Participants 753 784	randomly assigned after surgery
